Cargando…

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension

RATIONALE: Autoimmunity is believed to play a role in idiopathic pulmonary arterial hypertension (IPAH). It is not clear whether this is causative or a bystander of disease and if it carries any prognostic or treatment significance. OBJECTIVES: To study autoimmunity in IPAH using a large cross-secti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Rowena J., De Bie, Eckart M. D. D., Groves, Emily, Zalewska, Kasia I., Swietlik, Emilia M., Treacy, Carmen M., Martin, Jennifer M., Polwarth, Gary, Li, Wei, Guo, Jingxu, Baxendale, Helen E., Coleman, Stephen, Savinykh, Natalia, Coghlan, J. Gerry, Corris, Paul A., Howard, Luke S., Johnson, Martin K., Church, Colin, Kiely, David G., Lawrie, Allan, Lordan, James L., Mackenzie Ross, Robert V., Pepke Zaba, Joanna, Wilkins, Martin R., Wort, S. John, Fiorillo, Edoardo, Orrù, Valeria, Cucca, Francesco, Rhodes, Christopher J., Gräf, Stefan, Morrell, Nicholas W., McKinney, Eoin F., Wallace, Chris, Toshner, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613913/ https://www.ncbi.nlm.nih.gov/pubmed/35316153 http://dx.doi.org/10.1164/rccm.202108-1919OC

Ejemplares similares

Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020)

Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2021)

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
por: Rhodes, Christopher J., et al.
Publicado: (2017)

Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
por: Schwiening, Max, et al.
Publicado: (2022)

Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension
por: Soon, Elaine, et al.
Publicado: (2011)

Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
por: Kariotis, Sokratis, et al.
Publicado: (2021)

Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
por: Kariotis, Sokratis, et al.
Publicado: (2022)

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?
por: Peacock, Andrew J., et al.
Publicado: (2020)

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
por: Rhodes, Christopher J., et al.
Publicado: (2020)

Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
por: Karia, Nina, et al.
Publicado: (2023)

Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy
por: Wilkins, Martin R., et al.
Publicado: (2021)

Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis
por: Owen, Nicola E., et al.
Publicado: (2020)

The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease
por: Hadinnapola, Charaka, et al.
Publicado: (2015)

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2022)

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2012)

Application of Genetic Studies to Flow Cytometry Data and Its Impact on Therapeutic Intervention for Autoimmune Disease
por: Orrù, Valeria, et al.
Publicado: (2021)

Quantifying the Detrimental Effects of Multiple Freeze/Thaw Cycles on Primary Human Lymphocyte Survival and Function
por: Serra, Valentina, et al.
Publicado: (2022)

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
por: Hoole, Stephen P, et al.
Publicado: (2020)

First Genotype–Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease
por: Prapa, Matina, et al.
Publicado: (2022)

The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertension
por: Robertson, Lucy, et al.
Publicado: (2022)

EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study
por: Lewis, Robert A., et al.
Publicado: (2021)

Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2020)

Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension
por: Deboeck, Gaël, et al.
Publicado: (2014)

Author's reply
por: Pepke-Zaba, Joanna
Publicado: (2012)

(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study
por: Hagan, Guy, et al.
Publicado: (2011)

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
por: Gräf, Stefan, et al.
Publicado: (2018)

Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up
por: Rodgers, Matthew S., et al.
Publicado: (2022)

Comparison of Whole Blood Cryopreservation Methods for Extensive Flow Cytometry Immunophenotyping
por: Serra, Valentina, et al.
Publicado: (2022)

Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension
por: Hernández-Sánchez, Jules, et al.
Publicado: (2017)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension
por: Bunclark, Katherine, et al.
Publicado: (2021)

Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension
por: Ulrich, Anna, et al.
Publicado: (2020)

The role of genomics and genetics in pulmonary arterial hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2020)

‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2020)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

Carotid Beta Stiffness Association with Thyroid Function
por: Delitala, Alessandro P., et al.
Publicado: (2021)

Effect of Genetic Factors, Age and Sex on Levels of Circulating Extracellular Vesicles and Platelets
por: Orrù, Valeria, et al.
Publicado: (2023)

Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients
por: Kirkby, Louise C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pr33ul8fvpgu8di0sb1gdg3h2